Featured Video

Saturday, September 18, 2021

Trial Into Antioxidant for Parkinson's Disease Yields Disappointing Results

photo of lab tech in lab

The research team found no significant difference in the rate of disease progression for those given the metabolite inosine for two years compared to the placebo group.



from WebMD Health https://www.webmd.com/parkinsons-disease/news/20210917/trial-into-antioxidant-for-parkinsons-disease-yields-disappointing-results?src=RSS_PUBLIC

0 Comments:

Post a Comment